Recombinant interleukin-3 (Northwestern University)

重组白介素-3（Northwestern University）

Report date: 2022/01/14 13:23:58

Base Information

Drug NameRecombinant interleukin-3 (Northwestern University)
Drug Alias NameIL-3 (Northwestern University)Interleukin-3 (Northwestern University)
ClassificationBiologics > Protein drugs > Recombinant protein > Recombinant cytokines
Mechanisms of ActionInterleukin 3 receptor agonists
TargetsInterleukin 3 receptor
Therapy Area/IndicationsHIV Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPending (Clinical)
Highest Status in ChinaN/A
Originator CompaniesNorthwest University
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesNorthwest University
Active IndicationsN/A
Inactive IndicationsHIV Infections

Other Information

ATC CodeN/A
Related LinksN/A